Sean Tracy

5PUBLICATIONS
33CO-AUTHORS
Tumour immunologyGene and molecular therapyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 07, 2025
Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells.

Hrishi Venkatesh, Lynn Heltemes-Harris, Miriam Arroyo

|Oct 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar

|Jun 14, 2022
Ph-like gene alterations and complex chromosomal abnormalities are frequent in patients with acute lymphoblastic leukemia experiencing relapse after allogeneic hematopoietic cell transplantation.

Sean I Tracy, Qing Cao, Ben Bachan

|Mar 11, 2022
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.

Sean I Tracy, Hrishi Venkatesh, Can Hekim

|Mar 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.

Sean I Tracy, Melissa C Larson, Andrew L Feldman

Pageof 1

Frequent Collaborators

2 joint publications

Hrishi Venkatesh

2 joint publications

Lynn M Heltemes-Harris

2 joint publications

Michael A Farrar

1 joint publications

James R Cerhan